Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.

Details

Ressource 1Download: 34844180_BIB_225488014D1A.pdf (546.45 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_225488014D1A
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.
Journal
ESMO open
Author(s)
Keam B., Machiels J.P., Kim H.R., Licitra L., Golusinski W., Gregoire V., Lee Y.G., Belka C., Guo Y., Rajappa S.J., Tahara M., Azrif M., Ang M.K., Yang M.H., Wang C.H., Ng Q.S., Wan Zamaniah W.I., Kiyota N., Babu S., Yang K., Curigliano G., Peters S., Kim T.W., Yoshino T., Pentheroudakis G.
ISSN
2059-7029 (Electronic)
ISSN-L
2059-7029
Publication state
Published
Issued date
12/2021
Peer-reviewed
Oui
Volume
6
Number
6
Pages
100309
Language
english
Notes
Publication types: Practice Guideline
Publication Status: ppublish
Abstract
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of squamous cell carcinoma (SCC) of the oral cavity, larynx, oropharynx and hypopharynx was published in 2020. It was therefore decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special, virtual guidelines meeting in July 2021 to adapt the ESMO 2020 guidelines to consider the potential ethnic differences associated with the treatment of SCCs of the head and neck (SCCHN) in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with SCCHN (excluding nasopharyngeal carcinomas) representing the oncological societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of the current treatment practices and drug access restrictions in the different Asian countries. The latter was discussed when appropriate. This manuscript provides a series of expert recommendations (Clinical Practice Guidelines) which can be used to provide guidance to health care providers and clinicians for the optimisation of the diagnosis, treatment and management of patients with SCC of the oral cavity, larynx, oropharynx and hypopharynx across Asia.
Keywords
ESMO, Pan-Asian, guidelines, head and neck, squamous cell carcinoma, treatment
Pubmed
Web of science
Open Access
Yes
Create date
03/12/2021 10:03
Last modification date
23/11/2022 7:08
Usage data